Keith Joho has left his post as manager of computational biology at Roche Bioscience of Palo Alto, Calif., to become director of bioinformatics at Abgenix of Fremont, Calif. He was hired to start a bioinformatics program at Abgenix, a biopharmaceutical company focused on the development and commercialization of antibody therapies for a variety of diseases. “It’s rare that you have an opportunity to start up a new program from scratch and have good resources in a growing, dynamic company,” said Joho.
Sydney Brenner, the principal scientific advisor for Lynx Therapeutics of Hayward, Calif., has received the Special Achievement in Medical Sciences Award from the Lasker Foundation for his 50 years of accomplishments in biomedical science, including his work on the human genetic code and the model organism Caenorhabditis elegans. Brenner initially conceived Lynx’s technologies for massively parallel DNA sequencing and differential gene expression analysis and has played a significant role in implementing these technologies. In 1996, Brenner founded the Molecular Sciences Institute of Berkeley, Calif., to study the internal description of an organism through a combination of genomic biology, computation, and simulation.
Nobel Prize winner Kary Mullis and Volker Erdmann have joined the scientific advisory board of LabBook of McLean Va., a provider of XML-based life science informatics for biomedical researchers. Mullis, who won the 1993 Nobel Prize in chemistry for inventing the polymerase chain reaction, is currently vice president of molecular biology for Burstein Technologies of Irvine, Calif. Erdmann is director of the Institute of Biochemistry at the Freie Universitat in Berlin, Germany and is chairman of RiNA Netzwerk RNA-Technologien, also known as the RNA Network. LabBook’s enabling software, such as the Genomic XML-Browser queries, manages, and visualizes heterogeneous genomic data types and their underlying associations.
IBM has named Joe Jasinski as senior manager of the Blue Gene project and the Computational Biology Center. He replaced Andrea Califano, who has left the company. Jasinski, who has been at IBM for 18 years, was most recently involved in nanotechnology research.